Virios Therapeutics to Announce Q1 2024 Financial Results on May 9, 2024

Virios Therapeutics, Inc. (Nasdaq: VIRI), an innovative biotechnology company dedicated to developing antiviral therapies for chronic diseases such as fibromyalgia (FM) and Long-COVID (LC), has announced its schedule for releasing the financial results of the first quarter of 2024. The announcement is set for Thursday, May 9, 2024, prior to the opening of the financial markets. Additionally, the company’s management will host a webcast and conference call on the same day at 8:30 a.m. ET to discuss the financial outcomes and provide a corporate update. The webcast can be accessed live and later as an archive on the Virios Therapeutics website under the Investors section.

Virios Therapeutics specializes in creating antiviral treatments aimed at addressing chronic diseases that are believed to result from an abnormal immune response triggered by viral infections. Conditions like fibromyalgia, irritable bowel syndrome, Long-COVID, chronic fatigue syndrome, and other functional somatic syndromes are thought to be connected to an overactive immune response induced by tissue-resident herpesviruses. These diseases often exhibit fluctuating symptoms, which can be aggravated by factors that compromise the immune system.

The company's leading development candidates include innovative, proprietary fixed-dose combinations of an antiviral compound and celecoxib, which are intended to work together to reduce herpesvirus replication and alleviate disease symptoms. One of their notable candidates, IMC-1, a fixed-dose combination of famciclovir and celecoxib, has received fast track designation from the FDA, underscoring its potential to address unmet medical needs effectively.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!